Patel, Shreyaskumar <br/><br/>
Managing progressive disease in patients with GIST: factors to consider besides acquired secondary tyrosine kinase inhibitor resistance.  [electronic resource] 

 -  Cancer treatment reviews  Aug 2012 
 - 467-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1532-1967 
<br/><br/><label>Standard No.: </label>10.1016/j.ctrv.2011.10.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzamides<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm<br/>Gastrointestinal Neoplasms--drug therapy<br/>Gastrointestinal Stromal Tumors--drug therapy<br/>Humans<br/>Imatinib Mesylate<br/>Indoles--therapeutic use<br/>Patient Compliance<br/>Piperazines--therapeutic use<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrimidines--therapeutic use<br/>Pyrroles--therapeutic use<br/>Sunitinib